Back to YC Companies

    Atomic Alchemy

    Winter 2019
    Acquired

    We produce cancer-curing materials used in nuclear medicine.

    8 people View on YC

    Atomic Alchemy at a glance

    Y Combinator batch
    Winter 2019
    Status
    Acquired
    Industry
    Industrials
    Team size
    8 people
    Location
    Not recorded
    Website
    Not recorded

    Every field above comes from the Y Combinator company record. Nothing is estimated.

    Compare Atomic Alchemy with similar YC companies →

    About Atomic Alchemy

    Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments. Currently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine procedures, is sourced from just six government-run, scientific research reactors abroad. Five of these reactors are 45-65 years old and are quickly coming to the end of their operational life. This has cultivated a fragile and lengthy supply chain, at odds with the nature of radioactive material. This issue and its implications do not just effect molybdenum, but any other reactor-based isotope. Many promising cancer therapies are stuck in clinical trials, unable to secure enough material in a timely manner. Research doesn’t even happen because of the difficulty of sourcing any new isotopes. It doesn't have to be this way. Atomic Alchemy is working to solve this by building the world's first scalable radioisotope production facility. This facility will contain the world’s first privately-owned nuclear reactors dedicated to radioisotope production.

    Tags:
    Hard Tech
    Small Modular Reactors
    Medical Devices